|
|
|
|
|
|
Merck & Company (MRK)
|
|
66.16 +0.14 (+0.21%)
|
6/23/2017 4:00pm
|
|
Open:
|
66.04
|
Pre. Close:
|
66.02
|
|
High:
|
66.39
|
Low:
|
65.84
|
|
Volume:
|
14,093,453
|
Market Cap:
|
180.96B
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
66.59 - 66.92
|
66.92 - 67.31
|
|
Low:
|
64.8 - 65.17
|
65.17 - 65.62
|
|
Close:
|
65.51 - 66.09
|
66.09 - 66.78
|
|
|
|
|
|
|
Technical analysis (as of: 2017-06-23 4:36:41 PM)
|
|
Overall:
|
|
|
Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.
|
|
Target:
|
Six months: 77.54  One year: 90.57
|
|
Support:
|
Support1: 64.10 Support2: 62.69
|
|
Resistance:
|
Resistance1:
66.39 Resistance2: 77.54
|
|
Pivot:
|
64.50
|
|
Moving Averages:
|
MA(5): 65.17 MA(20): 64.62
MA(100): 64.08 MA(250): 62.30
|
|
MACD:
|
MACD(12,26):
0.35 Signal(12,26,9): 0.17
|
|
%K %D:
|
%K(14,3): 93.15 %D(3): 80.21
|
|
RSI:
|
RSI(14): 63.75
|
|
52-Week:
|
High: 66.80
Low: 55.10 Change(%): 14.7
|
|
Average Vol(K):
|
3-Month: 8504
10-Days 9312
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.MRK has closed below upper band by 9.5%. Bollinger Bands are 47.7% wider than normal. The large width of the bands suggest high volatility as compared to MRK's normal range. The bands have been in this wide range for 0 bars. This is a sign that the current trend might continue.
|
|
|
Headline News
|
|
Tue, 06 Jun 2017 13:20:18 GMT
Merck Reveals Its Gastric Cancer Hand
Thu, 15 Jun 2017 12:45:00 GMT
Merck: Why The Small Dividend Hikes?
Thu, 01 Jun 2017 16:07:30 GMT
Merck Wows Investors With Stellar Q1 Performance
Fri, 23 Jun 2017 11:48:45 GMT
Merck and Gilead among drug stocks buoyed by Trump's healthcare plans
Sat, 03 Jun 2017 20:15:00 GMT
Merck announces follow-up data with Merck's KEYTRUDA
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
